Selected Aortic Valve Procedures (CPB 0407, reviewed 2026-07-07)
Summary
Aetna considers the Ross pulmonary autograft procedure medically necessary for aortic valve replacement caused by congenital anomalies or aortic valve disease, and considers aortic valve-sparing re-implantation medically necessary for secondary aortic regurgitation from aortic root dilatation, such as in Marfan syndrome, and for type A acute aortic dissections. The Ross procedure and aortic valve-sparing re-implantation are considered experimental, investigational, or unproven for all other indications, and so are the Florida Sleeve valve-sparing procedure, Personalized External Aortic Root Support (PEARS), and the Matrix P bioprosthesis for pulmonary valve replacement in Ross procedures. the policy was last reviewed 07/07/2026.
Get alerts when payers change rules like this one
We check Aetna and other payers every day and email you when a change matches your specialty and state.